Nipocalimab Disease Interactions
There are 2 disease interactions with nipocalimab.
Nipocalimab (applies to nipocalimab) active or latent infection
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Nipocalimab may increase the risk of infection. Serious infections occurred in 7% of patients. Treatment with nipocalimab should be delayed in patients with an active infection until resolved. Nipocalimab may also reactivate latent viral infections, such as herpes zoster. Patients with positive hepatitis screening were excluded from clinical studies. Monitor patients closely for signs of infection during treatment. If serious infection occurs, withhold therapy and institute appropriate treatment, until the infection has resolved. Caution is advised in patients with latent viral infections.
References (1)
- (2025) "Product Information. Imaavy (nipocalimab)." Janssen Biotech, Inc.
Nipocalimab (applies to nipocalimab) liver and renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Renal Dysfunction
Nipocalimab has not been studied in patients with severe liver and renal impairment.
References (1)
- (2025) "Product Information. Imaavy (nipocalimab)." Janssen Biotech, Inc.
Switch to consumer interaction data
Nipocalimab drug interactions
There are 297 drug interactions with nipocalimab.
Report options
More about nipocalimab
- nipocalimab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Vyvgart
Vyvgart is used for myasthenia gravis to improve muscle weakness in adults whose myasthenia gravis ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Neostigmine
Neostigmine is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
